Electroconvulsive therapy (ECT) appears more effective than repetitive transcranial magnetic stimulation (rTMS) for short-term treatment of severe depression. This was the conclusion of a research study by Dr Savitha Eranti and colleagues that has been presented in the January 2007 issue of The American Journal Of Psychiatry (AJP).
A new study published in the Journal of Urology revealed that the prostate cancer treatments shorten penis. Men who receive combination treatment with hormone therapy plus radiation for local or locally advanced prostate cancer may experience a significant reduction in penile length.
Common cold virus could destroy cancer tumours, reported by British scientists. They are preparing to launch clinical trials of this new way to fight cancer by injecting viruses like the common cold into cancer cells.
Patients treated for gastro esophageal reflux disease (GERD) using the endoscopic Plicator procedure show long-term benefits in reducing reflux disease symptoms with no need for long-term prescription antacids, according to a study led by doctors at Beth Israel Deaconess Medical Center (BIDMC).
The Society for Cardiovascular Angiography and Interventions (SCAI) today released a clinical alert advising physicians on practical steps for reducing the risk of a rare but serious complication associated with drug-eluting stents. The document follows hearings held by the FDA’s Circulatory Systems Device Panel. SCAI’s clinical alert focuses on careful patient selection, meticulous stent implantation, and consistent use of medications to prevent the delayed formation of blood clots that can block blood flow to the heart.
Beta blockers, commonly used to treat high blood pressure and other heart conditions, may help to control central sleep apnea (CSA) in patients with congestive heart failure (CHF).
Researchers at the University of Pennsylvania School of Medicine have demonstrated the potential of a new type of therapy for patients who suffer from high cholesterol levels. The findings are in the January 11 issue of the New England Journal of Medicine (NEJM). In this study, patients with homozygous familial hypercholesterolemia (FH), a high-risk condition refractory to conventional therapy, had a remarkable 51 percent reduction in low-density lipoprotein (LDL) or “bad cholesterol” levels.
Researchers at Wake Forest University School of Medicine are the first to report that in animal studies, a common diabetes drug prevents the memory and learning problems that cancer patients often experience after whole-brain radiation treatments.
This release announces research that directly compared the early therapeutic response of drugs from widely used classes of heartburn medications, omeprazole magnesium, a proton pump inhibitor (PPI) and famotidine, a histamine-2 receptor antagonist (H2RAs), in an over-the-counter (OTC) setting.
New research shows that a recently discovered enzyme that destroys the messenger RNA (mRNA) for some proteins can also help to protect the mRNA during times of stress. The response might help cancer cells survive chemotherapy and radiation therapy. That enzyme attaches to certain mRNA molecules and remains there like a hand grenade with its pin in place.